Published November 1, 2008 | Version v1
Journal article

The plug-based nanovolume Microcapillary Protein Crystallization System (MPCS)

  • 1. Emerald BioSystems Inc., 7869 NE Day Road West, Bainbridge Island, WA 98110 (United States)
  • 2. deCODE biostructures Inc., 7869 NE Day Road West, Bainbridge Island, WA 98110 (United States)
  • 3. Accelerated Technologies Center for Gene to 3D Structure (United States)
  • 4. Seattle Structural Genomics Center for Infectious Disease (United States)
  • 5. Department of Biochemistry, University of Washington, Seattle, WA 98195 (United States)

Description

The Microcapillary Protein Crystallization System (MPCS) is a new protein-crystallization technology used to generate nanolitre-sized crystallization experiments for crystal screening and optimization. Using the MPCS, diffraction-ready crystals were grown in the plastic MPCS CrystalCard and were used to solve the structure of methionine-R-sulfoxide reductase. The Microcapillary Protein Crystallization System (MPCS) embodies a new semi-automated plug-based crystallization technology which enables nanolitre-volume screening of crystallization conditions in a plasticware format that allows crystals to be easily removed for traditional cryoprotection and X-ray diffraction data collection. Protein crystals grown in these plastic devices can be directly subjected to in situ X-ray diffraction studies. The MPCS integrates the formulation of crystallization cocktails with the preparation of the crystallization experiments. Within microfluidic Teflon tubing or the microfluidic circuitry of a plastic CrystalCard, ∼10–20 nl volume droplets are generated, each representing a microbatch-style crystallization experiment with a different chemical composition. The entire protein sample is utilized in crystallization experiments. Sparse-matrix screening and chemical gradient screening can be combined in one comprehensive 'hybrid' crystallization trial. The technology lends itself well to optimization by high-granularity gradient screening using optimization reagents such as precipitation agents, ligands or cryoprotectants

Availability note (English)

Available from http://dx.doi.org/10.1107/S0907444908028060; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585160

Additional details

Publishing Information

Journal Title
Acta Crystallographica. Section D: Biological Crystallography
Journal Volume
64
Journal Issue
Pt 11
Journal Page Range
p. 1116-1122
ISSN
0907-4449
CODEN
ABCRE6

Optional Information

Copyright
Copyright (c) Gerdts et al. 2008
Notes
PMCID: PMC2585160; PUBLISHER-ID: bw5254; PMID: 19020349; OAI: oai:pubmedcentral.nih.gov:2585160; This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.